Duloxetine 30 MG Delayed Release Oral Capsule — RxCUI 596930
RxNorm drug concept · Semantic clinical drug
RxCUI 596930
Semantic clinical drug · SCD
● Current RxNorm concept 117 FDA products
338 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI596930
Official nameDuloxetine 30 MG Delayed Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asduloxetine 30 MG (as duloxetine HCl 33.7 MG) Delayed Release Oral Capsule
FDA products mapped117
Package NDCs mapped338
Reported Medicaid activity (SDUD)4,098,603 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Duloxetine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- You're right to ask — duloxetine does a lot more than treat depression. It's also approved for generalized anxiety disorder, diabetic nerve pain, fibromyalgia, and chronic musculos...
- What is duloxetine actually used for? My doctor prescribed it but I wasn't sure it was just for depression.
- It depends on which product you have. Most duloxetine delayed-release capsules — including Cymbalta — must be swallowed whole. Crushing, chewing, or opening them damages the specia...
- Can I open the capsule or crush it if I have trouble swallowing pills?
🕸️ Concept Web — How Duloxetine 30 MG Delayed Release Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Duloxetine 30 MG Delayed Release Oral Capsule
RxCUI 596930 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Duloxetine
72625IN
-
Duloxetine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Cymbalta
482574BN
-
Cymbalta
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Duloxetine Delayed Release Oral Capsule
540628SCDF -
Duloxetine Oral Product
1161267SCDG -
Duloxetine Pill
1161268SCDG -
Duloxetine Delayed Release Oral Capsule [Cymbalta]
540631SBDF -
Cymbalta Oral Product
1174445SBDG -
Cymbalta Pill
1174446SBDG -
Delayed Release Oral Capsule
316995DF -
Oral Product
1151131DFG - +1 more in this family
-
Duloxetine Delayed Release Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Duloxetine 30 MG
596929SCDC -
Duloxetine 30 MG Delayed Release Oral Capsule [Cymbalta]
596932SBD -
Duloxetine 30 MG [Cymbalta]
596931SBDC
-
Duloxetine 30 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Duloxetine 30 MG
SCDC · 596929 -
Duloxetine Delayed Release Oral Capsule
SCDF · 540628 -
Duloxetine Oral Product
SCDG · 1161267 -
Duloxetine Pill
SCDG · 1161268
Brand-Name Concepts
-
Duloxetine 30 MG Delayed Release Oral Capsule [Cymbalta]
SBD · 596932 -
Duloxetine 30 MG [Cymbalta]
SBDC · 596931 -
Duloxetine Delayed Release Oral Capsule [Cymbalta]
SBDF · 540631 -
Cymbalta Oral Product
SBDG · 1174445 -
Cymbalta Pill
SBDG · 1174446 -
Cymbalta
BN · 482574
📦 FDA Products & Package NDCs
117 products · 338 package NDCs
338 package NDCs map to RxCUI 596930 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 76420-0633-05 | 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-633-05) | Duloxetine | Asclemed USA, Inc. | 2025-04-03 |
| 76420-0633-20 | 20 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-633-20) | Duloxetine | Asclemed USA, Inc. | 2025-04-03 |
| 76420-0633-30 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-633-30) | Duloxetine | Asclemed USA, Inc. | 2023-10-17 |
| 76420-0633-60 | 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-633-60) | Duloxetine | Asclemed USA, Inc. | 2023-10-17 |
| 76420-0633-90 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-633-90) | Duloxetine | Asclemed USA, Inc. | 2023-10-17 |
| 76420-0634-00 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-634-00) | Duloxetine | Asclemed USA, Inc. | 2025-04-03 |
| 76420-0634-01 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-634-01) | Duloxetine | Asclemed USA, Inc. | 2023-10-17 |
| 76420-0634-20 | 20 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-634-20) | Duloxetine | Asclemed USA, Inc. | 2025-04-03 |
| 76420-0634-30 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-634-30) | Duloxetine | Asclemed USA, Inc. | 2023-10-17 |
| 76420-0634-60 | 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-634-60) | Duloxetine | Asclemed USA, Inc. | 2023-10-17 |
| 76420-0634-90 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-634-90) | Duloxetine | Asclemed USA, Inc. | 2023-10-17 |
| 76420-0636-01 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-636-01) | Duloxetine | Asclemed USA, Inc. | 2023-10-17 |
| 76420-0636-20 | 20 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-636-20) | Duloxetine | Asclemed USA, Inc. | 2025-04-03 |
| 76420-0636-30 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-636-30) | Duloxetine | Asclemed USA, Inc. | 2023-10-17 |
| 76420-0636-90 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-636-90) | Duloxetine | Asclemed USA, Inc. | 2023-10-17 |
| 80425-0012-01 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0012-1) | Duloxetine HCL DR | Advanced Rx of Tennessee, LLC | 2020-09-25 |
| 80425-0012-02 | 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0012-2) | Duloxetine HCL DR | Advanced Rx of Tennessee, LLC | 2020-09-25 |
| 80425-0014-01 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0014-1) | Duloxetine HCL DR | Advanced Rx of Tennessee, LLC | 2022-12-11 |
| 80425-0014-02 | 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0014-2) | Duloxetine HCL DR | Advanced Rx of Tennessee, LLC | 2022-12-11 |
| 80425-0086-01 | 30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (80425-0086-... | Duloxetine HCL DR | Advanced Rx of Tennessee, LLC | 2013-12-17 |
| 80425-0086-02 | 60 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (80425-0086-... | Duloxetine HCL DR | Advanced Rx of Tennessee, LLC | 2013-12-17 |
| 80425-0146-01 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0146-1) | Duloxetine HCL DR | Advanced Rx Pharmacy of Tennessee, LLC | 2023-06-14 |
| 80425-0146-02 | 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0146-2) | Duloxetine HCL DR | Advanced Rx Pharmacy of Tennessee, LLC | 2023-06-14 |
| 80425-0146-03 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0146-3) | Duloxetine HCL DR | Advanced Rx Pharmacy of Tennessee, LLC | 2023-06-14 |
| 80425-0389-01 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0389-1) | Duloxetine | Advanced Rx of Tennessee, LLC | 2024-05-22 |
| 80425-0389-02 | 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0389-2) | Duloxetine | Advanced Rx of Tennessee, LLC | 2024-05-22 |
| 80425-0389-03 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0389-3) | Duloxetine | Advanced Rx of Tennessee, LLC | 2024-05-22 |
| 80425-0441-01 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0441-1) | Duloxetine | Advanced Rx of Tennessee, LLC | 2024-10-22 |
| 80425-0441-02 | 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0441-2) | Duloxetine | Advanced Rx of Tennessee, LLC | 2024-10-22 |
| 80425-0441-03 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0441-3) | Duloxetine | Advanced Rx of Tennessee, LLC | 2024-10-22 |
| 82009-0029-05 | 500 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (82009-029-... | Duloxetine | Quallent Pharmaceuticals Health, LLC | 2022-12-15 |
| 82009-0030-10 | 1000 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (82009-030... | Duloxetine | Quallent Pharmaceuticals Health, LLC | 2022-12-15 |
| 82009-0031-90 | 90 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (82009-031-9... | Duloxetine | Quallent Pharmaceuticals Health, LLC | 2023-06-01 |
| 82009-0032-10 | 1000 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (82009-032... | Duloxetine | Quallent Pharmaceuticals Health, LLC | 2022-12-15 |
| 82009-0170-10 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (82009-170-10) | Duloxetine | Quallent Pharmaceuticals Health LLC | 2025-07-01 |
| 82009-0171-10 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (82009-171-10) | Duloxetine | Quallent Pharmaceuticals Health LLC | 2025-07-01 |
| 82009-0172-30 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (82009-172-30) | Duloxetine | Quallent Pharmaceuticals Health LLC | 2025-07-01 |
| 82009-0173-10 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (82009-173-10) | Duloxetine | Quallent Pharmaceuticals Health LLC | 2025-07-01 |
Observed labelers:
Bryant Ranch Prepack (34) ·
Asclemed USA, Inc. (26) ·
Camber Pharmaceuticals, Inc. (19) ·
Sun Pharmaceutical Industries, Inc. (17) ·
Inventia Healthcare Limited. (15) ·
Ascend Laboratories, LLC (13)
· +31 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.